Zenithra S-1: Zero Revenue, Going Concern Warning, Seeks $100K IPO

TL;DR

**Zenithra's S-1 is a red flag; this pre-revenue shell company with a going concern warning is a pure gamble, avoid it.**

AI Summary

Zenithra Group Inc., incorporated on June 2, 2025, is an early-stage company planning to operate across e-commerce, IT, software development, new retail, and healthcare sectors. As of September 30, 2025, the company reported $nil in revenues and a net loss of $30,000. Zenithra is conducting an initial public offering of 100,000 shares of common stock at $1 per share, aiming to raise $100,000. The company's auditors have issued a "substantial doubt" going concern opinion, highlighting its dependence on this offering for continued operations. With monthly expenses of approximately $10,000, the $100,000 proceeds would only cover professional fees for SEC reporting, leaving no funds for business development. If $120,000 is raised, the company believes it would be sufficient for 12 months of business development. The offering is self-underwritten with no minimum, meaning any funds received are immediately available, but there's no assurance all shares will be sold. Post-offering, executive officers and directors will own 90.9% of common stock if all shares are sold, increasing to 97.56% if only 25% are sold.

Why It Matters

Zenithra Group's S-1 filing reveals a highly speculative investment opportunity, as the company has no revenue, a $30,000 net loss, and a going concern warning from its auditors. For investors, this means a high risk of capital loss, as the $100,000 target proceeds are barely enough to cover SEC reporting fees, not business development. Employees and customers are non-existent, given the company's early stage and lack of operations. The broader market impact is minimal, but it highlights the SEC's role in providing transparency for even the riskiest ventures, contrasting sharply with established tech and healthcare players.

Risk Assessment

Risk Level: high — The risk level is high due to Zenithra Group Inc.'s auditors issuing a "substantial doubt" going concern opinion, indicating significant uncertainty about its ability to continue operations for the next twelve months. The company reported $nil revenues and a net loss of $30,000 from June 2, 2025, to September 30, 2025, and states it has no current capital to fund business development, relying entirely on this offering to raise $100,000, which is primarily allocated to professional fees.

Analyst Insight

Investors should exercise extreme caution and likely avoid Zenithra Group Inc.'s offering. The company's pre-revenue status, significant going concern risk, and the fact that the $100,000 offering proceeds are insufficient for business development suggest a high probability of capital loss. Only investors with a very high-risk tolerance and understanding of early-stage, speculative ventures should consider this, and even then, with minimal capital.

Financial Highlights

debt To Equity

N/A

revenue

$nil

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

-$30,000

eps

N/A

gross Margin

N/A

cash Position

N/A

revenue Growth

N/A

Key Numbers

• $nil — Revenues (Reported from June 2, 2025, through September 30, 2025, indicating no operational income.)
• $30,000 — Net Loss (Incurred from June 2, 2025, through September 30, 2025, reflecting initial operational costs without revenue.)
• $10,000 — Monthly Expense Rate (The company's estimated monthly burn rate, highlighting its need for capital.)
• $100,000 — Target Offering Proceeds (The maximum amount Zenithra aims to raise, which is primarily for SEC reporting fees if fully subscribed.)
• 100,000 — Shares Offered (The total number of common stock shares being registered for sale in this IPO.)
• $1 — Offering Price Per Share (The fixed price at which shares are being sold for the duration of the offering.)
• 90.9% — Officer/Director Ownership (Percentage of common stock owned by executive officers and directors if 100% of the offering is sold, indicating high insider control.)
• 270 days — Offering Period (The maximum duration of the offering, unless extended by the board of directors.)
• June 2, 2025 — Incorporation Date (Zenithra Group Inc. was incorporated on this date, making it a very young company.)
• 1,000,000 — Shares Outstanding Pre-Offering (The number of common stock shares issued and outstanding before this offering.)

Key Players & Entities

• Zenithra Group Inc. (company) — Registrant in S-1 filing
• U.S. Securities and Exchange Commission (regulator) — Filing recipient
• Registered Agents Inc (company) — Agent for service of process
• $10,000 (dollar_amount) — Monthly expense rate
• $100,000 (dollar_amount) — Target capital raise from offering
• $120,000 (dollar_amount) — Amount deemed sufficient for 12 months of business development
• $30,000 (dollar_amount) — Net loss from June 2, 2025, to September 30, 2025
• $1 (dollar_amount) — Offering price per share
• 100,000 (dollar_amount) — Shares of common stock being registered
• 90.9% (dollar_amount) — Ownership of common stock by executive officers and directors if all shares are sold

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: Zenithra's independent auditors have issued a going concern opinion, expressing substantial doubt about the company's ability to continue as an ongoing business for the next twelve months. The financial statements do not reflect any adjustments for this uncertainty, meaning operations could cease, leading to a total loss for investors.
• Lack of Public Company Management Experience [high — operational]: The company's CEO, CFO, principal accounting officer, and directors lack significant experience managing a public company and financial reporting for public entities. This deficiency could impair the company's ability to comply with legal and regulatory requirements, including timely SEC filings and Sarbanes-Oxley Act compliance, jeopardizing its public company status.
• Dependence on External Financing [high — financial]: Zenithra has not generated any revenues and is currently operating at a loss. The company is entirely dependent on the continued availability of external financing to sustain its operations. Without this financing, the company may be forced to cease operations.
• Insufficient IPO Proceeds for Operations [high — financial]: The planned IPO aims to raise $100,000 by selling 100,000 shares at $1 per share. With monthly expenses of approximately $10,000, these proceeds would primarily cover SEC reporting professional fees, leaving no funds for business development. Even if $120,000 is raised, it is considered sufficient for only 12 months of business development.
• Self-Underwritten Offering Risk [medium — financial]: The offering is self-underwritten with no minimum requirement, meaning any funds received are immediately available. However, there is no assurance that all 100,000 shares will be sold, creating uncertainty about the total capital raised and its adequacy for operations.
• High Insider Ownership Post-Offering [medium — financial]: If all shares are sold in the IPO, executive officers and directors will own 90.9% of the common stock. If only 25% of the shares are sold, insider ownership increases to 97.56%. This concentration of ownership could limit the influence of public shareholders.

Industry Context

Zenithra plans to operate across diverse and competitive sectors including e-commerce, IT, software development, new retail, and healthcare. These industries are characterized by rapid technological advancements, intense competition, and evolving consumer demands. Success will require significant capital investment, strong execution, and the ability to innovate and adapt quickly to market changes.

Regulatory Implications

As a newly public company, Zenithra faces significant regulatory scrutiny, particularly concerning financial reporting and internal controls under the Sarbanes-Oxley Act. Management's lack of experience in these areas presents a high risk of non-compliance, which could lead to penalties and jeopardize its public listing.

What Investors Should Do

1. Assess the viability of Zenithra's business model given its lack of revenue and high burn rate.
2. Evaluate the management team's capability to navigate public company requirements and execute the business plan.
3. Consider the implications of high insider ownership and the lack of a minimum offering requirement.
4. Understand the 'going concern' opinion from auditors and its impact on the company's future.

Key Dates

• 2025-06-02: Incorporation Date — Zenithra Group Inc. was incorporated, marking the official start of the company's legal existence.
• 2025-09-30: End of Reporting Period — This date marks the end of the period for which financial statements are provided, showing $nil revenue and a $30,000 net loss.

Glossary

Going Concern

An accounting term indicating that a company is expected to remain in business for the foreseeable future (typically the next 12 months). A 'substantial doubt' means there is significant uncertainty about this. (Zenithra's auditors have expressed substantial doubt about its ability to continue as a going concern, highlighting its precarious financial state.)

Emerging Growth Company

A designation under the JOBS Act for companies with less than $1.235 billion in annual gross revenue (as of the IPO date). These companies are subject to reduced public company reporting requirements. (Zenithra qualifies as an emerging growth company, which allows for scaled disclosure requirements but also indicates its early stage.)

Self-Underwritten Offering

An offering where the issuer sells its securities directly to investors without the involvement of an underwriter. This means the company bears all the risk and responsibility for selling the shares. (Zenithra's offering is self-underwritten with no minimum, increasing the risk of insufficient capital being raised.)

Sarbanes-Oxley Act of 2002 (SOX)

A federal law that mandates certain practices in financial record keeping and reporting for public companies. It aims to protect investors from fraudulent accounting activities. (Zenithra's management lacks experience in SOX compliance, posing a significant risk to its ability to meet reporting requirements.)

Year-Over-Year Comparison

This is Zenithra Group Inc.'s initial S-1 filing, as the company was incorporated on June 2, 2025. Therefore, there are no prior year financial metrics or risk factors to compare against. The filing reflects the company's pre-revenue, early-stage status and its critical dependence on the success of this initial public offering for survival.

Key Financial Figures

• $10,000 — r monthly expense rate is approximately $10,000 per month. Our funds on hand will only
• $100,000 — eds section, we are attempting to raise $100,000 from this Offering. However, if we rais
• $120,000 — rom this Offering. However, if we raise $120,000 we feel this is sufficient to develop t
• $30,000 — report $nil revenues and a net loss of $30,000. This is our initial public offering.
• $1 — ny will be sold at a price per share of $1 for the duration of this Offering. 1
• $1,000,000,000 — h it had total annual gross revenues of $1,000,000,000 (as such amount is indexed for inflatio
• $75,000 — offered are sold, the proceeds will be $75,000, $50,000, or $25,000, respectively. Se
• $50,000 — are sold, the proceeds will be $75,000, $50,000, or $25,000, respectively. See “
• $25,000 — e proceeds will be $75,000, $50,000, or $25,000, respectively. See “Use of Proce
• $7,500 — n. The CCPA provides for fines of up to $7,500 per violation. It presently is unclear

Filing Documents

• ea0265768-s1_zenithra.htm (S-1) — 386KB
• ea026576801ex3-2_zenithra.htm (EX-3.2) — 131KB
• ea026576801ex5_zenithra.htm (EX-5) — 6KB
• ea026576801ex23-1_zenithra.htm (EX-23.1) — 2KB
• ea026576801ex-fee_zenithra.htm (EX-FILING FEES) — 12KB
• ex3-2_001.jpg (GRAPHIC) — 144KB
• 0001213900-25-113155.txt ( ) — 849KB
• ea026576801ex-fee_zenithra_htm.xml (XML) — 4KB

Use of Proceeds

Use of Proceeds 32 Determination of Offering Price 34

Dilution

Dilution 34 Selling Security Holders 35 Plan of Distribution 35

Description of Securities to be Registered

Description of Securities to be Registered 36 Interest of Named Experts and Counsel 38 Information with Respect to the Registrant 38 Description of property 40

Legal proceedings

Legal proceedings 40 Market price of and dividends of the registrant’s common equity and related stockholder matters 40

Financial statements and selected financial data

Financial statements and selected financial data F-1 i PROSPECTUS SUMMARY You should read the following summary together with the more detailed business information, financial statements and related notes that appear elsewhere in this Prospectus. In this Prospectus, unless the context otherwise denotes, references to “we,” “us,” “our”, “Zenithra Group Inc.”, “Zenithra”, and “the Company” are to Zenithra Group Inc.. We are an “emerging growth company” under the federal securities laws and will be subject to reduced public company reporting requirements. A Cautionary Note on Forward-Looking Statements This Prospectus contains forward-looking statements which relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled “Risk Factors,” that may cause our industry’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Except

RISK FACTORS

RISK FACTORS An investment in our common stock involves a high degree of risk. You should carefully consider the following material risks, together with the other information contained in this Prospectus, before you decide to buy our common stock. If any of the following risks actually occur, our business, results of operations and financial condition would likely suffer. In these circumstances, the market price of our common stock could decline, and you may lose all or part of your investment . Risks Relating to Our Business and Our Financial Condition: Our independent auditors have issued an audit opinion for the Company which includes a statement describing our going concern status. Our financial status creates a doubt whether we will continue as a going concern. As described in our accompanying financial statements, our auditors have issued a going concern opinion regarding the Company. This means there is substantial doubt we can continue as an ongoing business for the next twelve months. The financial statements do not include any adjustments that might result from the uncertainty regarding our ability to continue in business. As such, we may have to cease operations and investors could lose part or all of their investment in the Company. Our chief executive officer, chief financial officer and principal accounting officer, and directors have no significant experience managing a public company and no meaningful financial reporting experience as it relates to public companies. Accordingly, our ability to meet Exchange Act reporting requirements on a timely basis will be dependent to a significant degree upon others. Our officers and directors have no significant experience managing a public company and no meaningful financial reporting experience as it relates to public companies, which could impair our ability to comply with legal and regulatory requirements such as those imposed by the Sarbanes-Oxley Act of 2002. Such responsibilities include comply

View Full Filing

View this S-1 filing on SEC EDGAR